Meds Coupons

View Deals

8 Coupons

.
  • eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. .

    here are 4 mass. biotechs making noise at the ash conference so far .

    copyright © the asahi shimbun company. all rights reserved. no reproduction or republication without written permission.

  • .